BlueCrest Capital Management’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

BlueCrest Capital Management’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-200,000	Closed	-$2M	–	531
2021 Q2	$2M	Hold	200,000	–	–	0.06%	321
2021 Q1	$2.01M	Buy	+200,000	New	+$2M	0.05%	472

Other funds holding EBACU

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $574M AUM 6.51% 1-Year Est. Return

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $14.1B AUM 58.13% 1-Year Est. Return

Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return

Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Calamos Advisors

Calamos Advisors Naperville, Illinois $25.9B AUM 21.78% 1-Year Est. Return

Mint Tower Capital Management Amsterdam, Netherlands $1.08B AUM 19.06% 1-Year Est. Return